publication venue for
- Functional measures and AD biomarkers among Hispanic and White non-Hispanic older adults.. 16:-. 2024
- Neurocognitive profiles are associated with subsequent brain integrity in a sample of Hispanics/Latinos: Findings from the SOL-INCA-MRI study (HCHS/SOL).. 16:-. 2024
- Perceptions of cognitive decline among American Indian and Alaska Native elders.. 16:-. 2024
- Normative data for the Digit Symbol Substitution for diverse Hispanic/Latino adults: Results from the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).. 16:-. 2024
- Biomarkers of chronic inflammation and cognitive decline: A prospective observational study.. 16:-. 2024
- Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's disease.. 15:-. 2023
- Early-onset Alzheimer's disease explained by polygenic risk of late-onset disease?. 15:-. 2023
- Memory and language cognitive data harmonization across the United States and Mexico.. 15:-. 2023
- Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage.. 15:-. 2023
- Representativeness of samples enrolled in Alzheimer's disease research centers.. 15:-. 2023
- High school quality is associated with cognition 58 years later.. 15:-. 2023
- Feasibility of an online consensus approach for the diagnosis of cognitive impairment and dementia in rural South Africa.. 15:-. 2023
- A systematic review of measures of gender and biological sex: Exploring candidates for Alzheimer's disease and related dementias (AD/ADRD) research.. 15:-. 2023
- MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortium.. 14:-. 2022
- The relationship between Alzheimer's-related brain atrophy patterns and sleep macro-architecture.. 14:-. 2022
- Higher baseline levels of CSF inflammation increase risk of incident mild cognitive impairment and Alzheimer's disease dementia.. 14:-. 2022
- Medicare's Annual Wellness Visit and diagnoses of dementias and cognitive impairment.. 14:-. 2022
- Plasma biomarkers predict cognitive trajectories in an ethnoracially and clinically diverse cohort: Mediation with hippocampal volume.. 14:-. 2022
- Verbal fluency response times predict incident cognitive impairment.. 14:-. 2022
- The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum.. 14:-. 2022
- Instrumental validation of free water, peak-width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kits.. 14:-. 2022
- Blood biomarkers for cognitive decline and clinical progression in a Mexican American cohort.. 14:-. 2022
- Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI 2022
- Deep learning improves utility of tau PET in the study of Alzheimer's disease.. 13:-. 2021
- Large-scale sequencing studies expand the known genetic architecture of Alzheimer's disease.. 13:-. 2021
- Cognitive screening with functional assessment improves diagnostic accuracy and attenuates bias.. 13:-. 2021
- Normative data for the Brief Spanish-English Verbal Learning Test for representative and diverse Hispanics/Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).. 13:-. 2021
- Women's higher brain metabolic rate compensates for early Alzheimer's pathology.. 12:-. 2020
- ε. 12:-. 2020
- Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study.. 12:-. 2020
- The Meta VCI Map consortium for meta-analyses on strategic lesion locations for vascular cognitive impairment using lesion-symptom mapping: Design and multicenter pilot study.. 310-326. 2019
- Full exploitation of high dimensionality in brain imaging: The JPND working group statement and findings.. 286-290. 2019
- Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration.. 191-204. 2019
- Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease.. 595-598. 2018
- Sex differences in the association between apolipoprotein E ε4 allele and Alzheimer's disease markers.. 438-447. 2018
- Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease.. 285-300. 2018
- APOE. 188-195. 2017
- Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke.. 103-9. 2016
- A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings.. 1:387-94. 2015
- Retinal blood flow in mild cognitive impairment and Alzheimer's disease.. 1:144-51. 2015